| BRITANIN | |
| British museum leather dressing | |
| Bristle | |
| (10bS)-1,2,3,3aβ,6,7,8,9,10,10aα,13,13aβ-Dodecahydro-6α-acetoxy-1,1-dimethyl-7-methylene-5H-10β,13β-epoxy-5aβ,8β-methanocyclohepta[c]furo[3,4-e][1]benzopyran-5-one | 51419-50-2 |
| (10bS)-1,2,3,3aβ,6,7,8,9,10,10aα,13,13aβ-Dodecahydro-6α-acetoxy-10β-hydroxy-1,1-dimethyl-7-methylene-13-methoxy-5H-5aβ,8β-methanocyclohepta[c]furo[3,4-e][1]benzopyran-5-one | 51424-89-6 |
| BRK, active
| |
| BSAA I | |
| Brivax II vaccine | |
| Бриварацетам | 357336-20-0 |
| (4bS,8aβ,9α)-4b,5,6,7,8,8a,9,10-Octahydro-1,3,4-trimethoxy-4bα,8,8-trimethyl-2-isopropyl-9-phenanthrenol acetate | 60371-76-8 |
| (4bS,8aβ,9α)-4b,5,6,7,8,8a,9,10-Octahydro-1,3,4-trimethoxy-4bα,8,8-trimethyl-2-isopropyl-9-phenanthrenol | 60371-73-5 |
| (4bS,8aβ,9β)-4b,5,6,7,8,8a,9,10-Octahydro-1,3,4-trimethoxy-4bα,8,8-trimethyl-2-isopropyl-9-phenanthrenol | 60371-75-7 |
| BrkA protein | |
| BSAB I | |
| BSA (BIS-TRIMETHYLSILYL-D18) | |
| BSA, Biotin, SPDP
| |
| BSA (Bovine Serum Albumine MBG) 20 mg/ml
| |
| (4bS)-9α-Acetoxy-3,10β-dihydroxy-4bα,5,6,7,8,8aβ,9,10-octahydro-2-isopropyl-4bα,8,8-trimethyl-1,4-phenanthrenedione | |
| (4bS)-10β-Acetoxy-4b,5,6,7,8,8aβ,9,10-octahydro-3,9α-dihydroxy-2-isopropyl-4bα,8,8-trimethyl-1,4-phenanthrenedione | |
| (3bS)-6α-Acetoxy-7,7,10aβ-trimethyl-3bα,5aα,6,6aα,7,8,9,10,10a,10bα,10cβ,11-dodecahydro-4H-phenanthro[3,2-b:10,1-b'c']difuran-4-one | 40776-66-7 |
| (4bS)-7α-Acetoxy-5,6,7,8-tetrahydro-4-hydroxy-2-(1-hydroxy-1-methylethyl)-4bα,8,8-trimethylphenanthren-3(4bH)-one | 65714-87-6 |
| (4bS)-10α-Acetoxy-4b,5,6,7,8,8aβ,9,10-octahydro-3-hydroxy-4bα,8,8-trimethyl-2-isopropyl-1,4-phenanthrenedione | 77794-82-2 |
| BrkB protein | |
| BSA, chromatographically purified
| |
| BSA,CHICKENANTI- | |
| BRIVUDINE | 82768-44-3 |
| BSA, Clone: BGN/H8, Mab anti-, HRP, ELISA/IB
| |
| BSA, Clone: BGN/B2, Mab anti-, ELISA/IB
| |
| BSA, Clone: BSA-33, Mab anti-
| |
| BSA, Clone: BGN/D1, Mab anti-, ELISA/IB
| |
| BSA, COHN-Fraction V
| |
| BSA Derivatization Grade | |
| Brk25D protein | |
| BSA, FITC, SPDP
| |
| (10bS)-3aβ-Ethyl-2,3,3a,4,5,5aα,6,11,12,13aβ-decahydro-1H-indolizino[8,1-cd]carbazole | |
| BSA fluorescein conjugate | |
| BSA Fraction V, 50g | |
| BSA, Fraction V, Heat Shock Isolation, OMniPur(R) | |
| BSA Fraction V, chromatographically purified
| |
| BSA, Fraction V, Fatty Acid-Free, Nuclease- and Protease-Fre | |
| BSA, Fraction V, Fatty Acid-Poor, Endotoxin-Free | |
| BSA, Goat anti-
| |
| (4bS)-5,6,7,8,9,9aα-Hexahydro-2-fluoro-11-methyl-6β,9β-epiminobenz[a]azulen-10(4bαH)-one | |
| (4bS)-5,6,7,8,9,9aα-Hexahydro-3-methoxy-11-methyl-6β,9β-epiminobenz[a]azulen-10(4bαH)-one | |
| (11bS)-1,5,6,12,13,15aβ-Hexahydro-13-methoxy-2H,4H-[1,3]dioxolo[4,5-h]indolo[7a,1-a][2]benzazepine | |
| BSB | 56776-28-4 |
| Bsa29 I
| |
| BSA I | |
| BRL 54443 | 57477-39-1 |
| BRL 22321 | 72364-91-1 |
| BRL-45418 | |
| BRL-37344 | 90730-96-4 |
| BRL-47923 | |
| BRL-26830 | 77955-41-0 |
| BRL-44385 | |
| BRL-7116 | 5675-94-5 |
| BSA, IgG-free, Protease-free
| |
| BSA IN TBS- 10X SOLUTION
| |
| BSA-insulin-chlorin e(6) conjugate | |
| BSA (10% in H2O)
| |
| BSA IN PBS- 10X SOLUTION
| |
| BSA(347-359), ISOTOPIC LABELED | |
| (4bS)-1,4bα,5,8,8aα,9,10,10a-Octahydro-6,7,10aα-trimethylphenanthren-3(2H)-one | |
| (4bS)-1,4bα,5,8,8aα,9,10,10a-Octahydro-5β-methoxy-10aα-methylphenanthren-3(2H)-one | |
| (4bS)-4b,6a,10bα,10cβ-Tetrahydro-4bβ,6aα-diacetoxybenzo[3,4]cyclobuta[1,2-a]biphenylene | |
| (6bS)-6b,7aβ-Dihydro-6bβ-(4-fluorophenyl)-7H-cycloprop[a]acenaphthylene-7α-carbaldehyde | |
| (4bS)-4b,5,6,7,8,8aβ-Hexahydro-4-hydroxy-1-methoxy-4bα,8,8-trimethyl-2-isopropyl-3,9-phenanthrenedione | 60371-71-3 |
| (4bS)-4b,6,7,8,8aβ,10-Hexahydro-1,3,4-trimethoxy-4b,8,8-trimethyl-2-isopropyl-9(5H)-phenanthrenone | 60371-72-4 |
| (4bS)-4b,9b-Dihydro-4bβ,9bβ-dimethyl[1]benzoselenopheno[3,2-b][1]benzoselenophene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-2-fluoro-11-methyl-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-3-methoxy-11-methyl-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulen-3-ol | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-benzyl-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-2-fluoro-11-methyl-6β,9β-epiminobenz[a]azulen-10β-ol | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-2-methoxy-11-methyl-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4b,5,6,7,8,8aβ,9,10-Octahydro-3,10α-dihydroxy-2-isopropyl-4bα,8,8-trimethyl-1,4-phenanthrenedione | 21764-41-0 |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-(cyclopropylmethyl)-6β,9β-epiminobenz[a]azulene | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulen-10β-ol acetate | |
| (4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulen-10β-ol | 51805-82-4 |
| brlA protein | |
| (5bS)-5b,6,7,11bβ,12,13-Hexahydro-4,9,10-trimethoxy-5bβ,12-dimethylbenzo[c]-1,3-dioxolo[4,5-i]phenanthridin-6β-ol | |
| (6bS)-6bα,8,9,9aα-Tetrahydro-8-methylacenaphth[1,2-d]isoxazole-9β-carboxylic acid methyl ester | |
| (4bS)-4b,5,7aβ,8-Tetrahydro-6H-dibenzo[3,4:5,6]cyclohepta[1,2-b]furan-2,3,5α,8β,10,11-hexol | 65560-07-8 |
| BSA (10 mg/ml), FITC
| |
| BSA (10 mg/ml), TRITC
| |
| BSA M I | |
| (4bS)-1,2,4bβ,9bβ-Tetrahydrobenzofuro[3,2-b]benzofuran-4(3H)-one | |
| BSA, Negative Control, Gold 20 nm, EM
| |
| BSA, Negative Control, Gold 1 nm, EM/LM/Blotting/in sito hybrid.
| |
| BSA, Negative Control, Gold 5 nm, LM
| |
| BSA,NEGATIVECONTROL,GOLD5NM:EM | |
| BSA Polyclonal Antibody
| |
| BRLF1 protein | |
| BS14a protein, Arabidopsis thaliana | |
| BSA PRE DILUTED
| |
| BRK-1 protein | |
| BSA, Rabbit anti-, Agarose
| |
| BSA, Rabbit anti-
| |